AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
Conditions
Fertility Preservation · Lymphoma · Pediatrics Cancer · Gonadotropin-releasing Hormone Agonist
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre Hospitalier Chrétien (CHC)- Clinique de l'espérance, Montegnée, Liège, Belgium
Contact: Principal Investigator (Nadine Francotte)Universitair Ziekenhuis Antwerpen, Antwerp, Belgium
Contact: Principal Investigator (Joris Verlooy)Hôpital Universitaire Reine Fabiola (HUDERF), Brussels, Belgium
Contact: Principal Investigator (Alina Ferster)Universitair Ziekenhuis Brussels, Brussels, Belgium
Contact: Principal Investigator (Jutte Van der Werff)UZ-Gent, Ghent, Belgium
Contact: Principal Investigator (Els Vandecruys)Universitair Ziekenhuis Leuven, Leuven, Belgium
Contact: Principal Investigator (Anne Uyttebroeck)Centre Hospitalier Régional (CHR)-Citadelle, Liège, Belgium
Contact: Principal Investigator (Caroline Piette)Centre Oscar Lambret, Lille, France
Contact: Principal Investigator (Hélène Sudour-Bonnange)CHRU Lille-Hôpital Jeanne de Flandre, Lille, France
Contact: Principal Investigator (Benedicte Bruno)Hôpital Robert Debré, Paris, France
Contact: Principal Investigator (Jean- Hugue Dalle)
Study leads
Isabelle Demeestere, PhD
Study Director
Erasme ULB- Belgium
Alina Ferster
Principal Investigator
Queen Fabiola children's university hospital- Belgium
Christine Decanter
Principal Investigator
CHRU Lille, France